Lineage Cell Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Lineage Cell Therapeutics, Inc. (LCTX) reported Gain (Loss) on Disposition of Assets of -$31.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was -$19.00K.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was -$12.00K.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-03-31 was $0.00.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2015 was $3.69M.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2014 was $0.00.
- Lineage Cell Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2013 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$31.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$12.00K 10-Q · filed 2026-05-12 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | |||
| 2015-12-31 | $3.69M 10-K · filed 2017-03-16 | -$3.69M 10-K · filed 2016-03-15 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |